NCT00697320View on ClinicalTrials.gov

"Observational Study on the Efficacy and Safety of NovoSeven® During Real-life Usage in Germany"

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's DiseaseAcquired Bleeding DisorderAcquired Haemophilia
Interventions
DRUG

eptacog alfa (activated)

"A NON INTERVENTIONAL OBSERVATIONAL STUDY:~Doses and frequency of injections to be prescribed by the physician as a result of the normal clinical evaluation"

Trial Locations (1)

55127

Novo Nordisk Investigational Site, Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY